Thierry Lecomte

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Analysis of <i>PTEN</i> , <i>BRAF</i> , and <i>EGFR</i> Status in Determining Benefit From Cetuximab Therapy in Wild-Type <i>KRAS</i> Metastatic Colon Cancer

Pierre Laurent‐Puig, Anne Cayre, Gilles Manceau et al. · Journal of Clinical Oncology · 2009 · 665 citations

Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II

Georgia Malamut, Pauline Afchain, Virginie Verkarre et al. · Gastroenterology · 2008 · 365 citations

Refractory Celiac Disease, Food Intolerance, Long-term Follow-up +9

Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis

Thierry Lecomte, Anne Berger, Franck Zinzindohoué et al. · International Journal of Cancer · 2002 · 297 citations · Full text

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Florence Castan, Anthony Lopez et al. · JAMA Oncology · 2022 · 284 citations · Full text